Thursday, 23 November 2017

Market Live: Sensex, Nifty Continue To Trade Flat; Insurance Stocks Dip 3-6%

Posted by suhani varma on Thursday, November 23, 2017 with No comments



Live & Latest Intraday trading Stock Recommendations tomorrow, Stocks in news,Intraday tips free today, Stock market investment tips today and Tomorrow, intraday nifty and stocks Tips and call 23 November 2017, Nifty Trading Tips, nifty trend tomorrow, nifty stocks, nifty tips intrans, nifty tips provider, stock market investment for beginners, intraday stock tips, intraday trading intraday stocks watch today, best stocks to buy today and tomorrow, hot stocks to buy now, picks in shares of India 23 November 2017.
--------------------------------------------------------------------------------------------------------------------------------


BHEL, Infosys and Bharti Infratel were the top gainers, while Adani Ports, Dr Reddy’s Labs and Hindalco were the top losers.


Opto Circuits said the board has approves allotment of 4.5 crore shares on preferential basis at Rs 15 per share.

The price is much higher than the current share price. The stock rallied more than 12 percent.

Lasa Supergenerics share price rallied 5 percent intraday on beginning of pilot production trial runs at unit IV plant.


The company informed exchange that it is to start its pilot production trial runs in Unit IV from November 25.

"Products and capacity per annum will include Albendazole intermediate 400 MT, Fenbendazole intermediate 200 MT, 2 4 DCP 600 MT, Closantel intermediate 100 MT and additionally few components of backward integration for its recent new launches," the company said.

It further said the regular production will be subject to successful trial.

Lasa Supergenerics manufactures veterinary active pharmaceutical intermediate API.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com 
or visit http://www.ways2capital.com 
✆ - 0731-6626222 | Toll Free - 1800-3010-2007✔ 
Give a Missed Call for Free Trial - 09699997717

0 comments:

Post a Comment